Self-medication industry calls to be let off Class III hook and pharma rules for combinations
This article was originally published in Clinica
Executive Summary
The European Commission's proposed new EU regulation on medical devices is too dogmatic when it comes to the classification of drug/device combination products that are manufactured by the self-medication industry and used by consumers, and considered generally “low-risk”.